NCT04801095 - A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

August 8, 2025

Study Completion Date

August 8, 2025

Conditions

Advanced Solid TumorMetastatic Solid TumorColorectal CancerLung CancerPancreatic CancerCholangiocarcinomaHead and Neck Cancer

Interventions

DRUG

WM-S1-030

WM-S1-030 orally administered once daily (QD) for 28 days of each cycle.

Trial Locations (6)

RECRUITING

Austin Hospital, Heidelberg

RECRUITING

Monash Medical Center, Clayton

RECRUITING

Linear Clinical Research Limited, Nedlands

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

RECRUITING

Samsung Medical Center, Seoul